134 related articles for article (PubMed ID: 37956455)
21. Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.
Hernández-Ramírez LC; Gabrovska P; Dénes J; Stals K; Trivellin G; Tilley D; Ferrau F; Evanson J; Ellard S; Grossman AB; Roncaroli F; Gadelha MR; Korbonits M;
J Clin Endocrinol Metab; 2015 Sep; 100(9):E1242-54. PubMed ID: 26186299
[TBL] [Abstract][Full Text] [Related]
22. Sporadic pituitary adenomas: the role of germline mutations and recommendations for genetic screening.
Iacovazzo D; Hernández-Ramírez LC; Korbonits M
Expert Rev Endocrinol Metab; 2017 Mar; 12(2):143-153. PubMed ID: 30063429
[TBL] [Abstract][Full Text] [Related]
23. MEN4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations.
Seabrook A; Wijewardene A; De Sousa S; Wong T; Sheriff N; Gill AJ; Iyer R; Field M; Luxford C; Clifton-Bligh R; McCormack A; Tucker K
J Clin Endocrinol Metab; 2022 Jul; 107(8):2339-2349. PubMed ID: 35323929
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia.
Occhi G; Trivellin G; Ceccato F; De Lazzari P; Giorgi G; Demattè S; Grimaldi F; Castello R; Davì MV; Arnaldi G; Salviati L; Opocher G; Mantero F; Scaroni C
Eur J Endocrinol; 2010 Sep; 163(3):369-76. PubMed ID: 20530095
[TBL] [Abstract][Full Text] [Related]
25. Large genomic deletions in AIP in pituitary adenoma predisposition.
Georgitsi M; Heliövaara E; Paschke R; Kumar AV; Tischkowitz M; Vierimaa O; Salmela P; Sane T; De Menis E; Cannavò S; Gündogdu S; Lucassen A; Izatt L; Aylwin S; Bano G; Hodgson S; Koch CA; Karhu A; Aaltonen LA
J Clin Endocrinol Metab; 2008 Oct; 93(10):4146-51. PubMed ID: 18628514
[TBL] [Abstract][Full Text] [Related]
26.
Trofimiuk-Müldner M; Domagała B; Sokołowski G; Skalniak A; Hubalewska-Dydejczyk A
Front Endocrinol (Lausanne); 2023; 14():1098367. PubMed ID: 36843582
[TBL] [Abstract][Full Text] [Related]
27. Aryl hydrocarbon receptor interacting protein variants in sporadic pituitary adenomas.
Yu R; Bonert V; Saporta I; Raffel LJ; Melmed S
J Clin Endocrinol Metab; 2006 Dec; 91(12):5126-9. PubMed ID: 17018653
[TBL] [Abstract][Full Text] [Related]
28. High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.
Tichomirowa MA; Barlier A; Daly AF; Jaffrain-Rea ML; Ronchi C; Yaneva M; Urban JD; Petrossians P; Elenkova A; Tabarin A; Desailloud R; Maiter D; Schürmeyer T; Cozzi R; Theodoropoulou M; Sievers C; Bernabeu I; Naves LA; Chabre O; Montañana CF; Hana V; Halaby G; Delemer B; Aizpún JI; Sonnet E; Longás AF; Hagelstein MT; Caron P; Stalla GK; Bours V; Zacharieva S; Spada A; Brue T; Beckers A
Eur J Endocrinol; 2011 Oct; 165(4):509-15. PubMed ID: 21753072
[TBL] [Abstract][Full Text] [Related]
29. Risk category system to identify pituitary adenoma patients with
Caimari F; Hernández-Ramírez LC; Dang MN; Gabrovska P; Iacovazzo D; Stals K; Ellard S; Korbonits M;
J Med Genet; 2018 Apr; 55(4):254-260. PubMed ID: 29440248
[TBL] [Abstract][Full Text] [Related]
30. Clinical and genetic characteristics in patients under 30 years with sporadic pituitary adenomas.
Martínez de LaPiscina I; Portillo Najera N; Rica I; Gaztambide S; Webb SM; Santos A; Moure MD; Paja Fano M; Hernandez MI; Chueca-Guindelain MJ; Hernández-Ramírez LC; Soto A; Valdés N; Castaño L
Eur J Endocrinol; 2021 Aug; 185(4):485-496. PubMed ID: 34313605
[TBL] [Abstract][Full Text] [Related]
31. Aggressive prolactinoma in a child related to germline mutation in the ARYL hydrocarbon receptor interacting protein (AIP) gene.
Naves LA; Jaffrain-Rea ML; Vêncio SA; Jacomini CZ; Casulari LA; Daly AF; Beckers A
Arq Bras Endocrinol Metabol; 2010 Nov; 54(8):761-7. PubMed ID: 21340166
[TBL] [Abstract][Full Text] [Related]
32. Low frequency of AIP mutations in patients with young-onset sporadic pituitary macroadenomas.
Gaspar LM; Gonçalves CI; Saraiva C; Cortez L; Amaral C; Nobre E; Lemos MC
J Endocrinol Invest; 2023 Nov; 46(11):2299-2307. PubMed ID: 37149543
[TBL] [Abstract][Full Text] [Related]
33. The Genomic Landscape of Sporadic Prolactinomas.
De Sousa SMC; Wang PPS; Santoreneos S; Shen A; Yates CJ; Babic M; Eshraghi L; Feng J; Koszyca B; Roberts-Thomson S; Schreiber AW; Torpy DJ; Scott HS
Endocr Pathol; 2019 Dec; 30(4):318-328. PubMed ID: 31473917
[TBL] [Abstract][Full Text] [Related]
34. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
[TBL] [Abstract][Full Text] [Related]
35. The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations.
Ozawa A; Agarwal SK; Mateo CM; Burns AL; Rice TS; Kennedy PA; Quigley CM; Simonds WF; Weinstein LS; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
J Clin Endocrinol Metab; 2007 May; 92(5):1948-51. PubMed ID: 17299066
[TBL] [Abstract][Full Text] [Related]
36. Pituitary adenoma predisposition caused by germline mutations in the AIP gene.
Vierimaa O; Georgitsi M; Lehtonen R; Vahteristo P; Kokko A; Raitila A; Tuppurainen K; Ebeling TM; Salmela PI; Paschke R; Gündogdu S; De Menis E; Mäkinen MJ; Launonen V; Karhu A; Aaltonen LA
Science; 2006 May; 312(5777):1228-30. PubMed ID: 16728643
[TBL] [Abstract][Full Text] [Related]
37. Mutation analysis of inhibitory guanine nucleotide binding protein alpha (GNAI) loci in young and familial pituitary adenomas.
Demir H; Donner I; Kivipelto L; Kuismin O; Schalin-Jäntti C; De Menis E; Karhu A
PLoS One; 2014; 9(10):e109897. PubMed ID: 25291362
[TBL] [Abstract][Full Text] [Related]
38. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas.
Georgitsi M; De Menis E; Cannavò S; Mäkinen MJ; Tuppurainen K; Pauletto P; Curtò L; Weil RJ; Paschke R; Zielinski G; Wasik A; Lubinski J; Vahteristo P; Karhu A; Aaltonen LA
Clin Endocrinol (Oxf); 2008 Oct; 69(4):621-7. PubMed ID: 18410548
[TBL] [Abstract][Full Text] [Related]
39. Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma.
Hao W; Skarulis MC; Simonds WF; Weinstein LS; Agarwal SK; Mateo C; James-Newton L; Hobbs GR; Gibril F; Jensen RT; Marx SJ
J Clin Endocrinol Metab; 2004 Aug; 89(8):3776-84. PubMed ID: 15292304
[TBL] [Abstract][Full Text] [Related]
40. Whole-exome identifies RXRG and TH germline variants in familial isolated prolactinoma.
Melo FM; Couto PP; Bale AE; Bastos-Rodrigues L; Passos FM; Lisboa RG; Ng JM; Curran T; Dias EP; Friedman E; De Marco L
Cancer Genet; 2016 Jun; 209(6):251-7. PubMed ID: 27245436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
